IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
Top Cited Papers
- 8 January 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6781) , eadt0559
Abstract
Identifying the cell of origin that harbors an initial driver mutation is key to understanding tumor evolution and for the development of new treatments. For isocitrate dehydrogenase (IDH)–mutant gliomas, the most common malignant primary brain tumor in young adults, the cell of origin is currently poorly understood. We conducted deep sequencing on 142 tissues from 70 individuals comprising tumors, peritumoral cortex or subventricular zones, and blood. Low-level IDH mutations were found in the peritumoral cortex in 37.9% (11 of 29) of patients. Integrating cell-type–specific mutation analysis, the direction of clonal evolution, spatial transcriptomics from patient brains, and a cancer mouse model arising from mutant oligodendrocyte progenitor cell, we determined that glial progenitor cells harboring an initial IDH mutation were responsible for the development of IDH-mutant gliomas.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (2019R1A3B206661923)
- National Research Foundation of Korea (RS-2025-00523374)
- Korea Health Industry Development Institute (MD-PhD/Medical Scientist Training Program)
- National Research Foundation of Korea (NRF2022M3C1A309202211)
- Korea Health Industry Development Institute (RS-2024-00438443)
- National Research Foundation of Korea (RS-2024-00437820)
- Korea Health Industry Development Institute (RS-2024-00405260)
- Sovargen
- German Research Foundation (498037705)
This publication has 112 references indexed in Scilit:
- Ultra‐Low Level Somatic Mutations and Structural Variations in Focal Cortical Dysplasia Type IIAnnals of Neurology, 2023
- Somatic variation in normal tissues: friend or foe of cancer early detection?Annals of Oncology, 2022
- Complex heatmap visualizationiMeta, 2022
- NG2 expression in NG2 glia is regulated by binding of SoxE and bHLH transcription factors to a Cspg4 intronic enhancerGlia, 2018
- Somatic mutations in neurons during aging and neurodegenerationActa Neuropathologica, 2018
- Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early GliomagenesisCancer Cell, 2016
- Adult oligodendrocyte progenitor cells – Multifaceted regulators of the CNS in health and diseaseBrain, Behavior, and Immunity, 2016
- IDHMutation in GliomaJAMA Neurology, 2014
- IFN-γ and TNF-α Synergistically Induce Mesenchymal Stem Cell Impairment and Tumorigenesis via NFκB SignalingStem Cells, 2013
- Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines*†Medical and Pediatric Oncology, 2001